Abilene Nuclear LLC dba National Central Pharmacy
FDA inspection history in Abilene, Texas, 2019 to 2020
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2019: one Form 483; 2020: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2019–20One Form 483 and one warning letter, at Abilene, Texas.
Cited most
Across all Abilene Nuclear LLC dba National Central Pharmacy observations on file
- 21 CFR 211.113Control of microbiological contamination6
- 21 CFR 211.188Batch production and control records1
- 21 CFR 211.42Design and construction features1
The complete Abilene Nuclear LLC dba National Central Pharmacy file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Abilene, Texas
One warning letter and one Form 483 · 2019 to 2020 · 8 observations
Latest: Warning letter, Oct 22, 2020 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2020-10-22 | Warning letter Warning letter | Abilene, Texas | — | $99 |
| 2019-11-07 | 483 Form 483 | Abilene, Texas | 8 | $99 |
Investigators on these documents
FEI number 3004819860 · most recent document Oct 22, 2020
About Abilene Nuclear LLC dba National Central Pharmacy
How many FDA Form 483s has Abilene Nuclear LLC dba National Central Pharmacy received?
FDA Intel has 1 Form 483 on file for Abilene Nuclear LLC dba National Central Pharmacy; the most recent is dated Nov 7, 2019.
When was Abilene Nuclear LLC dba National Central Pharmacy last inspected by FDA?
The most recent FDA inspection document on file for Abilene Nuclear LLC dba National Central Pharmacy is a Form 483 dated Nov 7, 2019, for the site in Abilene, Texas.
What did FDA cite at Abilene Nuclear LLC dba National Central Pharmacy?
The regulations cited most in the observations on file for Abilene Nuclear LLC dba National Central Pharmacy are 21 CFR 211.113 (Control of microbiological contamination), 6 times; 21 CFR 211.188 (Batch production and control records), 1 time; 21 CFR 211.42 (Design and construction features), 1 time.
Has Abilene Nuclear LLC dba National Central Pharmacy received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Abilene Nuclear LLC dba National Central Pharmacy; the most recent is dated Oct 22, 2020.